On behalf of the GMMMG Clinical Reference Group, we now seek comments on two consultations.
These consultations will run for six weeks and close at 5pm on Friday 27th February 2026. To take part, visit the consultations page.
CRG actions January 2026
Actions in this consultation include:
- Azathioprine oral suspension – amber shared care
- Vutrisiran – red
- Sotrovimab – remove from formulary (product discontinued
All links to NICE clinical guidelines and MHRA drug safety updates will be added to formulary as appropriate.
Methylphenidate shared care protocol
We now seek comments on a draft shared care protocol for methylphenidate for children and adolescents. This is an update to an existing GMMMG shared care protocol.